STOCK TITAN

The Joint (JYNT) Stock News, Jan-May 2024

JYNT Nasdaq

The Joint Corp. reports developments in its U.S. chiropractic clinic franchise system through The Joint Chiropractic® network. Company news centers on earnings releases, franchise development, patient-access partnerships, clinic operations, and the shift of its clinic portfolio toward a more franchised operating model.

Recurring updates also cover refranchising activity, regional developer arrangements, share repurchases, executive and operating leadership changes, and initiatives tied to patient experience and franchisee economics. The company’s business model combines retail healthcare access with chiropractic care delivered through franchised, managed, and company-operated clinics.

Rhea-AI Summary

The Joint Corp. has engaged Capstone Partners to accelerate its refranchising efforts. The agreement aims to select effective franchisees to support system growth and increase asset value. Capstone will help identify qualified franchisees for large transactions, enhancing value for stakeholders. The Joint Corp. is a leader in retail chiropractic, offering strong unit economics and growth opportunities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none
-
Rhea-AI Summary

The Joint Corp. (NASDAQ: JYNT) will participate in two upcoming investor conferences held by B. Riley and Oppenheimer. President and CEO Peter Holt, along with CFO Jake Singleton, will represent the company. Interested investors can access a webcast of the Oppenheimer presentation on the company's investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.15%
Tags
conferences
-
Rhea-AI Summary

The Joint Corp. reported its financial results for the first quarter of 2024, showing a 5% revenue growth, 9% system-wide sales increase, and 3% system-wide comp sales rise compared to Q1 2023. The company also tripled franchise license sales, opened 23 clinics, and closed four, increasing the clinic count to 954. Adjusted EBITDA was $3.5 million, net income was $947,000, and operating income improved from a loss to $1.1 million. The company aims to be the 'Champions of Chiropractic' and highlighted their progress in revenue growth and refranchising efforts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25.35%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.83%
Tags
conferences earnings date
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.95%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.98%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.56%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings date
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.49%
Tags
none

FAQ

What is the current stock price of The Joint (JYNT)?

The Joint (JYNT) last closed at $7.04.

What is the market cap of The Joint (JYNT)?

The market cap of The Joint (JYNT) is approximately $99.6M.